You are on Trendlyne United States. Click here to go to India website or make United States as your default

Vivos Therapeutics Inc XNAS: VVOS

Vivos Therapeutics Inc Live Share Price Today, Share Analysis and Chart

2.55 -0.02 (-0.78%)

59.39% Fall from 52W High

48,641 XNAS Volume

XNAS 04 Apr, 2025 5:30 PM (EDT)


Vivos Therapeutics Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '252012.51517.5Actual RevenueAvg. Estimate
Miss

Vivos Therapeutics Inc's Revenue was lower than average estimate 3 times in past 3 years

EPS forecast

Current EPS
-1
Avg. Estimate
-1
Low Estimate
-1
High Estimate
-1
Current EPS
Avg. Estimate

Consensus Recommendation

2 ANALYST Recommendations
STRONG BUY

Created with Highcharts 7.2.22Strong Buy

The consensus recommendation from 2 analysts for Vivos Therapeutics Inc is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Vivos Therapeutics Inc Stock Analysis

Vivos Therapeutics Inc stock analysis with key metrics, changes, and trends.

Vivos Therapeutics Inc MetricVALUECHANGE %TRENDANALYSIS
Stock Price$2.55-18.79%negative

Stock Price fell 18.79% and underperformed its sector by 17.7% in the past year.

Mutual Fund Holding2.29 %0.11%positive

Mutual Fund Holding increased by 0.11% in the last quarter to 2.29.

Institutional Holding8.38 %0%neutral

Institutional Holding remained the same in the last quarter at 8.38%.



Loading data..

Vivos Therapeutics Inc - Company Profile

What does Vivos Therapeutics Inc do?

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Vivos Therapeutics Inc Management structure

All Gross Remunerations are in USD
Mr. Bradford K. Amman
Chief Financial Officer, Treasurer, Secretary and Principal Accounting Officer
-
2024
Gross Remuneration
Year
Mr. R. Kirk Huntsman
Chairman of the Board and Chief Executive Officer
-
2024
Gross Remuneration
Year

Vivos Therapeutics Inc Board of directors

All Gross Remunerations are in USD
Mr. Leonard J. Sokolow
Independent Director
-
2024
Gross Remuneration
Year
Ms. Anja Krammer
Independent Director
-
2024
Gross Remuneration
Year
Dr. Matthew Thompson, M.D.
Independent Director
-
2024
Gross Remuneration
Year
Mr. R. Kirk Huntsman
Chairman of the Board and Chief Executive Officer
-
2024
Gross Remuneration
Year
Dr. Ralph E. Green, D.D.S.,M.B.A.
Independent Director
-
2024
Gross Remuneration
Year
Mr. Mark F. Lindsay
Independent Director
-
2024
Gross Remuneration
Year

Vivos Therapeutics Inc FAQ

How is Vivos Therapeutics Inc today?
Vivos Therapeutics Inc today is trading in the red, and is down by -0.78% at 2.55.
Vivos Therapeutics Inc is currently trading down -0.78% on an intraday basis. In the past week the stock fell -18.01%. stock has been down -42.95% in the past quarter and fell -18.79% in the past year. You can view this in the overview section.